Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 87076

4 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
November 20, 2020
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Complete Pharmacy and Medical Solutions, LLC.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

4 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 4

HUMAN CHORIONIC GONADOTROPIN 11,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035

D-0234-2021
Recall number
D-0234-2021
Initiated
November 20, 2020
Classification
Class II
Status
Terminated
Quantity
1182 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP deviations: Lack of potency testing.

Code information

Lot #: 40568 Use By Date: 01/30/2021

Distribution pattern

Distributed Nationwide in the USA

drug · product 2 of 4

HUMAN CHORIONIC GONADOTROPIN 6,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035

D-0235-2021
Recall number
D-0235-2021
Initiated
November 20, 2020
Classification
Class II
Status
Terminated
Quantity
2418 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP deviations: Lack of potency testing.

Code information

Lot# 40604 Use By date, 01/30/2021

Distribution pattern

Distributed Nationwide in the USA

drug · product 3 of 4

HUMAN CHORIONIC GONADOTROPIN 5,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035

D-0236-2021
Recall number
D-0236-2021
Initiated
November 20, 2020
Classification
Class II
Status
Terminated
Quantity
1144 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP deviations: Lack of potency testing.

Code information

Lot #: 40570 Use By Date 01/30/2021

Distribution pattern

Distributed Nationwide in the USA

drug · product 4 of 4

HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035

D-0237-2021
Recall number
D-0237-2021
Initiated
November 20, 2020
Classification
Class II
Status
Terminated
Quantity
2400 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP deviations: Lack of potency testing.

Code information

Lot #: 40548, Use By Date, 01/30/2021.

Distribution pattern

Distributed Nationwide in the USA